Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Meningioma | Research

Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review

Authors: Xiaoxi Zhu, Yanhua Liu, Weiwei Guo, Qi Liang, Chengliang Pan, Bin Tan, Ying Yu

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Backgrounds

Lymphoplasmacyte-rich meningioma(LPM) is a rare subtype of meningioma with a low degree of malignancy and an overall preferable prognosis. The purpose of this article is to increase the understanding of the disease, reduce misdiagnosis, and improve prognosis.

Methods

A search was conducted in the PubMed database for English articles published from 1993 to 2023. The keywords were "lymphoplasmacyte-rich (all fields) and meningioma (all fields) and English (lang)" and "lymphoplasmacyte-rich meningioma (title/abstract) and English (lang)".We further analyzed the clinical manifestations, imaging manifestations, pathological features, treatment strategies, and prognosis of LPM.The possible prognostic indicators were analyzed by the log-rank test and Pearson’s chi-squared test.

Results

Fourteen reports with 95 LPM patients were included in this report, including 47 males and 48 females who were diagnosed between the ages of 9 and 79, with an average age of 45 years. The most common clinical manifestations are headache and limb movement disorders. In most cases, the tumor occurred on the convex portion of the brain. All tumors showed significant enhancement, with homogeneous enhancement being more common, and most patients showed peritumoral edema. Postoperative pathological EMA, LCA, and vimentin positivity were helpful for the final diagnosis of the patient. Log-rank tests showed a correlation between complete resection and better prognosis and recurrence.

Conclusion

There is a lack of significant differences in the clinical symptoms and imaging manifestations of LPM compared to other diseases that need to be differentiated, and a clear diagnosis requires pathological examination. After standardized surgical treatment, the recurrence rate and mortality rate of LPM are both low. Complete surgical resection of tumors is associated with a better prognosis and lower recurrence rate.
Literature
2.
go back to reference Banerjee AK, Blackwood W. A subfrontal tumour with the features of plasmocytoma and meningioma. Acta Neuropathol. 1971;18(1):84–8.PubMedCrossRef Banerjee AK, Blackwood W. A subfrontal tumour with the features of plasmocytoma and meningioma. Acta Neuropathol. 1971;18(1):84–8.PubMedCrossRef
3.
go back to reference Moradi A, et al. Pathodiagnostic parameters for meningioma grading. J Clin Neurosci. 2008;15(12):1370–5.PubMedCrossRef Moradi A, et al. Pathodiagnostic parameters for meningioma grading. J Clin Neurosci. 2008;15(12):1370–5.PubMedCrossRef
4.
go back to reference Wang YB, et al. Intraventricular lymphoplasmacyte-rich meningioma: a case report. Turk Neurosurg. 2014;24(6):958–62.PubMed Wang YB, et al. Intraventricular lymphoplasmacyte-rich meningioma: a case report. Turk Neurosurg. 2014;24(6):958–62.PubMed
5.
go back to reference Liu JL, et al. An analysis of the magnetic resonance imaging and pathology of intracal lymphoplasmacyte-rich meningioma. Eur J Radiol. 2012;81(5):968–73.PubMedCrossRef Liu JL, et al. An analysis of the magnetic resonance imaging and pathology of intracal lymphoplasmacyte-rich meningioma. Eur J Radiol. 2012;81(5):968–73.PubMedCrossRef
6.
go back to reference Yongjun L, et al. Imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma. J Craniofac Surg. 2015;26(2):e132–7.PubMedCrossRef Yongjun L, et al. Imaging findings and clinical features of intracal lymphoplasmacyte-rich meningioma. J Craniofac Surg. 2015;26(2):e132–7.PubMedCrossRef
7.
go back to reference Wang H, et al. Lymphoplasmacyte-rich meningioma in the central nervous system: An unusual case report. Medicine (Baltimore). 2021;100(52):e27991.PubMedCrossRef Wang H, et al. Lymphoplasmacyte-rich meningioma in the central nervous system: An unusual case report. Medicine (Baltimore). 2021;100(52):e27991.PubMedCrossRef
8.
go back to reference Zhu HD, et al. Lymphoplasmacyte-rich meningioma: our experience with 19 cases and a systematic literature review. Int J Clin Exp Med. 2013;6(7):504–15.PubMedPubMedCentral Zhu HD, et al. Lymphoplasmacyte-rich meningioma: our experience with 19 cases and a systematic literature review. Int J Clin Exp Med. 2013;6(7):504–15.PubMedPubMedCentral
10.
go back to reference Nohara H, et al. Lymphoplasmacyte-rich meningioma with atypical invasive nature. Neurol Med Chir (Tokyo). 2007;47(1):32–5.PubMedCrossRef Nohara H, et al. Lymphoplasmacyte-rich meningioma with atypical invasive nature. Neurol Med Chir (Tokyo). 2007;47(1):32–5.PubMedCrossRef
11.
go back to reference Tao X, et al. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2017;106:152–64.PubMedCrossRef Tao X, et al. Clinical, Radiologic, and Pathologic Features of 56 Cases of Intracranial Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2017;106:152–64.PubMedCrossRef
12.
go back to reference Hosler MR, et al. Idiopathic hypertrophic pachymeningitis mimicking lymphoplasmacyte-rich meningioma. J Neuroophthalmol. 2007;27(2):95–8.PubMedCrossRef Hosler MR, et al. Idiopathic hypertrophic pachymeningitis mimicking lymphoplasmacyte-rich meningioma. J Neuroophthalmol. 2007;27(2):95–8.PubMedCrossRef
13.
go back to reference Nambirajan A, et al. Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma. Childs Nerv Syst. 2019;35(8):1423–7.PubMedCrossRef Nambirajan A, et al. Large dural-based mass with bony hyperostosis in a 16-year-old male: IgG4-related disease mimicking lymphoplasmacyte-rich meningioma. Childs Nerv Syst. 2019;35(8):1423–7.PubMedCrossRef
14.
go back to reference Tanboon J, et al. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration. Clin Neuropathol. 2013;32(4):291–7.PubMedCrossRef Tanboon J, et al. Probable IgG4-related pachymeningitis: a case with transverse sinus obliteration. Clin Neuropathol. 2013;32(4):291–7.PubMedCrossRef
15.
go back to reference Kanno H, et al. A case of lymphoplasmacyte-rich meningioma of the jugular foramen. Brain Tumor Pathol. 2011;28(4):341–5.PubMedCrossRef Kanno H, et al. A case of lymphoplasmacyte-rich meningioma of the jugular foramen. Brain Tumor Pathol. 2011;28(4):341–5.PubMedCrossRef
16.
go back to reference Jie D, et al. Clinical features, radiological findings, and prognostic factors for primary intracranial chordoid meningioma. Front Neurol. 2022;13:1002088.PubMedPubMedCentralCrossRef Jie D, et al. Clinical features, radiological findings, and prognostic factors for primary intracranial chordoid meningioma. Front Neurol. 2022;13:1002088.PubMedPubMedCentralCrossRef
17.
go back to reference Patnana M, et al. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol. 2012;198(3):W217–27.PubMedCrossRef Patnana M, et al. Inflammatory pseudotumor: the great mimicker. AJR Am J Roentgenol. 2012;198(3):W217–27.PubMedCrossRef
18.
go back to reference Schlimper C, et al. Radiologic features of inflammatory pseudotumors. Rofo. 2005;177(11):1506–12.PubMedCrossRef Schlimper C, et al. Radiologic features of inflammatory pseudotumors. Rofo. 2005;177(11):1506–12.PubMedCrossRef
20.
go back to reference Häusler M, et al. Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review. Hum Pathol. 2003;34(3):253–62.PubMedCrossRef Häusler M, et al. Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review. Hum Pathol. 2003;34(3):253–62.PubMedCrossRef
21.
go back to reference Suri V, et al. Intracranial inflammatory pseudotumor: report of a rare case. Neuropathology. 2008;28(4):444–7.PubMedCrossRef Suri V, et al. Intracranial inflammatory pseudotumor: report of a rare case. Neuropathology. 2008;28(4):444–7.PubMedCrossRef
22.
go back to reference Aizawa T, et al. Intramedullary plasma cell granuloma in the cervicothoracic spine. Case report J Neurosurg. 2002;97(2 Suppl):235–8.PubMed Aizawa T, et al. Intramedullary plasma cell granuloma in the cervicothoracic spine. Case report J Neurosurg. 2002;97(2 Suppl):235–8.PubMed
23.
go back to reference Lui PC, et al. Inflammatory pseudotumors of the central nervous system. Hum Pathol. 2009;40(11):1611–7.PubMedCrossRef Lui PC, et al. Inflammatory pseudotumors of the central nervous system. Hum Pathol. 2009;40(11):1611–7.PubMedCrossRef
24.
go back to reference Kitai R, et al. Meningeal sinus histiocytosis mimicking lymphoplasmacyte-rich meningioma. Case report J Neurosurg. 1996;84(6):1051–4.PubMed Kitai R, et al. Meningeal sinus histiocytosis mimicking lymphoplasmacyte-rich meningioma. Case report J Neurosurg. 1996;84(6):1051–4.PubMed
25.
go back to reference Wang Y, et al. Primary Intraosseous Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2018;109:291–3.PubMedCrossRef Wang Y, et al. Primary Intraosseous Lymphoplasmacyte-Rich Meningioma. World Neurosurg. 2018;109:291–3.PubMedCrossRef
26.
go back to reference de Almeida GB, Januário G. Lymphoplasmacyte-rich meningioma: A rare histologic variant of benign meningioma with atypical bone invasion. Radiol Case Rep. 2022;17(3):922–7.PubMedPubMedCentralCrossRef de Almeida GB, Januário G. Lymphoplasmacyte-rich meningioma: A rare histologic variant of benign meningioma with atypical bone invasion. Radiol Case Rep. 2022;17(3):922–7.PubMedPubMedCentralCrossRef
29.
go back to reference Yang X, et al. Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. Neurology. 2018;90(20):934–5.PubMedCrossRef Yang X, et al. Lymphoplasmacyte-rich meningioma involving the whole intracranial dura mater. Neurology. 2018;90(20):934–5.PubMedCrossRef
30.
go back to reference Avninder S, Gupta V, Sharma KC. Lymphoplasmacyte-rich meningioma at the foramen magnum. Br J Neurosurg. 2008;22(5):702–4.PubMedCrossRef Avninder S, Gupta V, Sharma KC. Lymphoplasmacyte-rich meningioma at the foramen magnum. Br J Neurosurg. 2008;22(5):702–4.PubMedCrossRef
31.
go back to reference Majumdar K, et al. Sphenoid wing lymphoplasmacyte-rich meningioma with occasional emperipolesis closely simulating an intracranial Rosai-Dorfman disease: a diagnostic dilemma. Clin Neuropathol. 2013;32(2):122–7.PubMedCrossRef Majumdar K, et al. Sphenoid wing lymphoplasmacyte-rich meningioma with occasional emperipolesis closely simulating an intracranial Rosai-Dorfman disease: a diagnostic dilemma. Clin Neuropathol. 2013;32(2):122–7.PubMedCrossRef
32.
go back to reference Fukui K, et al. A rare case of dumbbell-shaped lymphoplasmacyte-rich meningioma arising at the upper cervical spinal cord. J Orthop Sci. 2021. Fukui K, et al. A rare case of dumbbell-shaped lymphoplasmacyte-rich meningioma arising at the upper cervical spinal cord. J Orthop Sci. 2021.
33.
go back to reference Go KG, Wilmink JT, Molenaar WM. Peritumoral brain edema associated with meningiomas. Neurosurgery. 1988;23(2):175–9.PubMedCrossRef Go KG, Wilmink JT, Molenaar WM. Peritumoral brain edema associated with meningiomas. Neurosurgery. 1988;23(2):175–9.PubMedCrossRef
35.
go back to reference Hou J, et al. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus. 2013;35(6):E2.PubMedCrossRef Hou J, et al. Peritumoral brain edema in intracranial meningiomas: the emergence of vascular endothelial growth factor-directed therapy. Neurosurg Focus. 2013;35(6):E2.PubMedCrossRef
36.
go back to reference Yoshioka H, et al. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer. 1999;85(4):936–44.PubMedCrossRef Yoshioka H, et al. Peritumoral brain edema associated with meningioma: influence of vascular endothelial growth factor expression and vascular blood supply. Cancer. 1999;85(4):936–44.PubMedCrossRef
37.
go back to reference Samoto K, et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 1995;55(5):1189–93.PubMed Samoto K, et al. Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res. 1995;55(5):1189–93.PubMed
38.
go back to reference Ding YS, et al. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas. Ann Clin Lab Sci. 2008;38(4):344–51.PubMed Ding YS, et al. Expression of vascular endothelial growth factor in human meningiomas and peritumoral brain areas. Ann Clin Lab Sci. 2008;38(4):344–51.PubMed
39.
40.
go back to reference Bitzer M, et al. Tumor-related venous obstruction and development of peritumoral brain edema in meningiomas. Neurosurgery. 1998;42(4):730–7.PubMedCrossRef Bitzer M, et al. Tumor-related venous obstruction and development of peritumoral brain edema in meningiomas. Neurosurgery. 1998;42(4):730–7.PubMedCrossRef
41.
go back to reference Bradac GB, et al. Peritumoral edema in meningiomas A radiological and histological study. Neuroradiology. 1986;28(4):304–12.PubMedCrossRef Bradac GB, et al. Peritumoral edema in meningiomas A radiological and histological study. Neuroradiology. 1986;28(4):304–12.PubMedCrossRef
42.
go back to reference Wang DJ, et al. Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution. Int J Clin Exp Pathol. 2013;6(3):358–74.PubMedPubMedCentral Wang DJ, et al. Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution. Int J Clin Exp Pathol. 2013;6(3):358–74.PubMedPubMedCentral
43.
go back to reference Osawa T, et al. Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neurooncol. 2013;111(1):49–57.PubMedCrossRef Osawa T, et al. Factors affecting peritumoral brain edema in meningioma: special histological subtypes with prominently extensive edema. J Neurooncol. 2013;111(1):49–57.PubMedCrossRef
44.
go back to reference Park KJ, et al. Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas. J Neurosurg. 2010;112(1):73–80.PubMedCrossRef Park KJ, et al. Influence of interleukin-6 on the development of peritumoral brain edema in meningiomas. J Neurosurg. 2010;112(1):73–80.PubMedCrossRef
45.
go back to reference Frati A, et al. Peritumoral Brain Edema in Relation to Tumor Size Is a Variable That Influences the Risk of Recurrence in Intracranial Meningiomas. Tomography. 2022;8(4):1987–96.PubMedPubMedCentralCrossRef Frati A, et al. Peritumoral Brain Edema in Relation to Tumor Size Is a Variable That Influences the Risk of Recurrence in Intracranial Meningiomas. Tomography. 2022;8(4):1987–96.PubMedPubMedCentralCrossRef
46.
go back to reference Horten BC, Urich H, Stefoski D. Meningiomas with conspicuous plasma cell-lymphocytic components: a report of five cases. Cancer. 1979;43(1):258–64.PubMedCrossRef Horten BC, Urich H, Stefoski D. Meningiomas with conspicuous plasma cell-lymphocytic components: a report of five cases. Cancer. 1979;43(1):258–64.PubMedCrossRef
47.
go back to reference Gi H, et al. Meningioma with hypergammaglobulinemia. Case report J Neurosurg. 1990;73(4):628–9.PubMed Gi H, et al. Meningioma with hypergammaglobulinemia. Case report J Neurosurg. 1990;73(4):628–9.PubMed
48.
go back to reference Weidenheim KM, Campbell WG Jr, Goldman HW. Atypical monoclonal plasma cell hyperplasia of the central nervous system: precursor of plasmacytoma with evolutionary considerations. Neurosurgery. 1989;24(3):429–34.PubMedCrossRef Weidenheim KM, Campbell WG Jr, Goldman HW. Atypical monoclonal plasma cell hyperplasia of the central nervous system: precursor of plasmacytoma with evolutionary considerations. Neurosurgery. 1989;24(3):429–34.PubMedCrossRef
49.
go back to reference Gregorios JB, Bay JW, Dudley AW Jr. Extramedullary hematopoiesis in a malignant meningioma. Neurosurgery. 1983;13(4):447–51.PubMedCrossRef Gregorios JB, Bay JW, Dudley AW Jr. Extramedullary hematopoiesis in a malignant meningioma. Neurosurgery. 1983;13(4):447–51.PubMedCrossRef
50.
go back to reference Kepes JJ, et al. “Chordoid” meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome A report of seven cases. Cancer. 1988;62(2):391–406.PubMedCrossRef Kepes JJ, et al. “Chordoid” meningeal tumors in young individuals with peritumoral lymphoplasmacellular infiltrates causing systemic manifestations of the Castleman syndrome A report of seven cases. Cancer. 1988;62(2):391–406.PubMedCrossRef
51.
go back to reference Cao L, Li H. Enhancement of blurry retinal image based on non-uniform contrast stretching and intensity transfer. Med Biol Eng Comput. 2020;58(3):483–96.PubMedCrossRef Cao L, Li H. Enhancement of blurry retinal image based on non-uniform contrast stretching and intensity transfer. Med Biol Eng Comput. 2020;58(3):483–96.PubMedCrossRef
52.
go back to reference Mehmood A, et al. A non-uniform quantization scheme for visualization of CT images. Math Biosci Eng. 2021;18(4):4311–26.PubMedCrossRef Mehmood A, et al. A non-uniform quantization scheme for visualization of CT images. Math Biosci Eng. 2021;18(4):4311–26.PubMedCrossRef
53.
go back to reference Sundarapandian M, Kalpathi R, Manason VD. DSA image registration using non-uniform MRF model and pivotal control points. Comput Med Imaging Graph. 2013;37(4):323–36.PubMedCrossRef Sundarapandian M, Kalpathi R, Manason VD. DSA image registration using non-uniform MRF model and pivotal control points. Comput Med Imaging Graph. 2013;37(4):323–36.PubMedCrossRef
Metadata
Title
Epidemiology, characteristics, and prognostic factors of lymphoplasmacyte-rich meningioma: a systematic literature review
Authors
Xiaoxi Zhu
Yanhua Liu
Weiwei Guo
Qi Liang
Chengliang Pan
Bin Tan
Ying Yu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-023-11811-4

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine